AMY HOLLEN: Open Payments
NPI 1750463816 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,352 in 68 payments from 21 companies in 2025. Trend: 2023 $1,241 · 2024 $1,344 · 2025 $1,352
Food & beverage: $1,352
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $277 |
| Novo Nordisk Inc | 10 | $188 |
| AstraZeneca Pharmaceuticals LP | 6 | $136 |
| PFIZER INC. | 4 | $97 |
| Janssen Pharmaceuticals, Inc | 3 | $87 |
| GlaxoSmithKline, LLC. | 3 | $70 |
| Lilly USA, LLC | 4 | $68 |
| Teva Pharmaceuticals USA, Inc. | 2 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| Axsome Therapeutics, Inc. | 2 | $49 |
Products named: QULIPTA, AIRSUPRA, SPRAVATO, Rybelsus, VRAYLAR, TRELEGY ELLIPTA, Ozempic, Wegovy.
Industry payments across MI — which companies pay providers there.
